GB9929297D0 - Process - Google Patents
ProcessInfo
- Publication number
- GB9929297D0 GB9929297D0 GBGB9929297.1A GB9929297A GB9929297D0 GB 9929297 D0 GB9929297 D0 GB 9929297D0 GB 9929297 A GB9929297 A GB 9929297A GB 9929297 D0 GB9929297 D0 GB 9929297D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- formula
- pharmaceutically acceptable
- acceptable salt
- diamide
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000003839 salts Chemical class 0.000 abstract 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
Priority Applications (24)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9929297.1A GB9929297D0 (en) | 1999-12-11 | 1999-12-11 | Process |
| CNB008170177A CN1224609C (zh) | 1999-12-11 | 2000-12-08 | 制备具有抗肥胖和抗糖尿病性质的芳基乙醇胺衍生物的方法 |
| PCT/GB2000/004697 WO2001042195A1 (en) | 1999-12-11 | 2000-12-08 | Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
| PT00985495T PT1235788E (pt) | 1999-12-11 | 2000-12-08 | Processo para a preparacao de derivados de ariletanolamina com propriedades anti-obesidade e anti-diabeticas |
| HK02107499.9A HK1045988B (en) | 1999-12-11 | 2000-12-08 | Method for preparing arylethanolamine derivatives with anti-obesity and anti-diabetic properties |
| DE60019157T DE60019157T2 (de) | 1999-12-11 | 2000-12-08 | Herstellungsverfahren von arylethanolaminderivate zur behandlung von diabetes und fettleibigkeit |
| IL14958500A IL149585A0 (en) | 1999-12-11 | 2000-12-08 | Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties |
| NZ518795A NZ518795A (en) | 1999-12-11 | 2000-12-08 | Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties |
| BRPI0016187A BRPI0016187B1 (pt) | 1999-12-11 | 2000-12-08 | processo para a preparação de derivados de aril etanol amina tendo propriedades anti-obesidade e anti-diabéticas |
| KR1020027007383A KR100683614B1 (ko) | 1999-12-11 | 2000-12-08 | 항-비만 및 항-당뇨 특성을 갖는 아릴에탄올아민 유도체의제조 방법 |
| HU0203640A HU229043B1 (hu) | 1999-12-11 | 2000-12-08 | Eljárás obesitas-ellenes és antidiabetikus tulajdonságokkal rendelkezõ (aril-etanol)-amin-származékok elõállítására |
| CA2394117A CA2394117C (en) | 1999-12-11 | 2000-12-08 | Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties |
| PL356483A PL200540B1 (pl) | 1999-12-11 | 2000-12-08 | Sposób wytwarzania biarylowych pochodnych i związki pośrednie |
| US10/148,841 US6548523B2 (en) | 1999-12-11 | 2000-12-08 | Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
| TR2002/01528T TR200201528T2 (tr) | 1999-12-11 | 2000-12-08 | Anti-obezite ve anti-diyabetik özellikleri olan ariletanolamin türevlerinin hazırlanmasına yönelik proses |
| SI200030676T SI1235788T1 (cg-RX-API-DMAC10.html) | 1999-12-11 | 2000-12-08 | |
| AT00985495T ATE292110T1 (de) | 1999-12-11 | 2000-12-08 | Herstellungsverfahren von arylethanolaminderivate zur behandlung von diabetes und fettleibigkeit |
| AU21911/01A AU769387B2 (en) | 1999-12-11 | 2000-12-08 | Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
| ES00985495T ES2236020T3 (es) | 1999-12-11 | 2000-12-08 | Procedimiento para la preparacion de derivados de ariletanolamina con propiedades antiobesidad y antidiabeticas. |
| EP00985495A EP1235788B1 (en) | 1999-12-11 | 2000-12-08 | Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
| JP2001543497A JP4903964B2 (ja) | 1999-12-11 | 2000-12-08 | 抗−肥満および抗−糖尿病特性を有するアリールエタノールアミン誘導体の調製法 |
| CZ20022017A CZ303143B6 (cs) | 1999-12-11 | 2000-12-08 | Zpusob výroby arylethanolaminových derivátu s antiobezitními a antidiabetickými vlastnostmi |
| ZA200204585A ZA200204585B (en) | 1999-12-11 | 2002-06-07 | Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties. |
| NO20022758A NO323239B1 (no) | 1999-12-11 | 2002-06-10 | Fremgangsmate for fremstilling av aryletanolaminderivater med antifedme og antidiabetiske egenskaper, mellomprodukter og fremgangsmate for fremstilling av disse. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9929297.1A GB9929297D0 (en) | 1999-12-11 | 1999-12-11 | Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9929297D0 true GB9929297D0 (en) | 2000-02-02 |
Family
ID=10866125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9929297.1A Ceased GB9929297D0 (en) | 1999-12-11 | 1999-12-11 | Process |
Country Status (23)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10230147A1 (de) * | 2001-10-09 | 2004-01-15 | Profos Ag | Verfahren zur unspezifischen Anreicherung von Bakterienzellen |
| US7158049B2 (en) * | 2003-03-24 | 2007-01-02 | Schlumberger Technology Corporation | Wireless communication circuit |
| US8213085B2 (en) * | 2008-01-18 | 2012-07-03 | Visera Technologies Company Limited | Image sensor device with high photosensitivity |
| US8778998B2 (en) | 2009-04-10 | 2014-07-15 | Auspex Pharmaceuticals, Inc. | Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor |
| US9907767B2 (en) | 2010-08-03 | 2018-03-06 | Velicept Therapeutics, Inc. | Pharmaceutical compositions and the treatment of overactive bladder |
| PE20131341A1 (es) | 2010-08-03 | 2013-12-07 | Altherx Inc | Combinaciones de agonistas del receptor beta-3-adrenergico y antagonistas del receptor muscarinico para tratar vejiga hiperactiva |
| TW201338772A (zh) | 2012-02-09 | 2013-10-01 | Altherx Inc | 藥學組合物 |
| MX2017007054A (es) | 2014-12-03 | 2018-05-02 | Velicept Therapeutics Inc | Composiciones y métodos para usar solabegron de liberación modificada para sintomas del tracto urinario inferior. |
| CN108290824B (zh) | 2015-10-23 | 2022-03-11 | B3Ar治疗股份有限公司 | 索拉贝隆两性离子及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1551260A (en) | 1976-02-09 | 1979-08-30 | Allen & Hanburys Ltd | Phenylethanolamine derivatives |
| JP2577222B2 (ja) * | 1987-04-10 | 1997-01-29 | 興和株式会社 | 新規な置換アニリド誘導体 |
| NO179246C (no) * | 1991-11-20 | 1996-09-04 | Sankyo Co | Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav |
| GB9525121D0 (en) * | 1995-12-08 | 1996-02-07 | Glaxo Group Ltd | Chemical compounds |
| SK16282000A3 (sk) * | 1998-05-01 | 2001-05-10 | Abbott Laboratories | Substituované beta-aminokyselinové inhibítory metionínaminopeptidázy-2 |
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
-
1999
- 1999-12-11 GB GBGB9929297.1A patent/GB9929297D0/en not_active Ceased
-
2000
- 2000-12-08 BR BRPI0016187A patent/BRPI0016187B1/pt not_active IP Right Cessation
- 2000-12-08 AU AU21911/01A patent/AU769387B2/en not_active Ceased
- 2000-12-08 CA CA2394117A patent/CA2394117C/en not_active Expired - Fee Related
- 2000-12-08 KR KR1020027007383A patent/KR100683614B1/ko not_active Expired - Fee Related
- 2000-12-08 EP EP00985495A patent/EP1235788B1/en not_active Expired - Lifetime
- 2000-12-08 CZ CZ20022017A patent/CZ303143B6/cs not_active IP Right Cessation
- 2000-12-08 US US10/148,841 patent/US6548523B2/en not_active Expired - Lifetime
- 2000-12-08 ES ES00985495T patent/ES2236020T3/es not_active Expired - Lifetime
- 2000-12-08 PL PL356483A patent/PL200540B1/pl unknown
- 2000-12-08 AT AT00985495T patent/ATE292110T1/de active
- 2000-12-08 IL IL14958500A patent/IL149585A0/xx not_active IP Right Cessation
- 2000-12-08 HK HK02107499.9A patent/HK1045988B/en not_active IP Right Cessation
- 2000-12-08 DE DE60019157T patent/DE60019157T2/de not_active Expired - Lifetime
- 2000-12-08 HU HU0203640A patent/HU229043B1/hu not_active IP Right Cessation
- 2000-12-08 PT PT00985495T patent/PT1235788E/pt unknown
- 2000-12-08 WO PCT/GB2000/004697 patent/WO2001042195A1/en not_active Ceased
- 2000-12-08 CN CNB008170177A patent/CN1224609C/zh not_active Expired - Fee Related
- 2000-12-08 JP JP2001543497A patent/JP4903964B2/ja not_active Expired - Fee Related
- 2000-12-08 NZ NZ518795A patent/NZ518795A/en unknown
- 2000-12-08 TR TR2002/01528T patent/TR200201528T2/xx unknown
-
2002
- 2002-06-07 ZA ZA200204585A patent/ZA200204585B/xx unknown
- 2002-06-10 NO NO20022758A patent/NO323239B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
| HU0101336D0 (en) | Process for the preparation of perindopril and their pharmaceutically acceptable salts | |
| CY1106743T1 (el) | Μεθοδος παρασκευης θειαμεθοξαμης | |
| HK1053831A1 (zh) | 作为治疗药物的激酶抑制剂 | |
| GB9914486D0 (en) | Medicaments | |
| DE69831868D1 (en) | Antithrombosemittel | |
| HUT75226A (en) | Naphthalene derivatives as prostaglandin i2 agonits, pharmaceutical compns. contg. them and process for preparing them | |
| CZ305838B6 (cs) | N-(2-arylethyl)benzylaminy jako antagonisté receptoru 5-HT6 | |
| HU0102272D0 (en) | Compositions and methods for stimulating gastrointestinal motilis | |
| GC0000375A (en) | Benzodiazepine derivatives as gaba a receptor modulators | |
| BG101250A (en) | Salts of an anti-migraine indole derivative | |
| IL145005A0 (en) | 4-OXO-4, 7-DIHYDRO-THIENO[2,3-b] PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS | |
| NZ334954A (en) | Substituted heterocycles as anti-tumor agents | |
| YU94103A (sh) | Novi derivati sulfonske kiseline | |
| CA2373117A1 (en) | 13-methyl-erythromycin derivatives | |
| UA66866C2 (uk) | Синтез морфолінових похідних | |
| IL149585A0 (en) | Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties | |
| IL154014A0 (en) | Process for the preparation of 2-aminoethylpyridines | |
| MXPA01011955A (es) | Aminoacidos policiclicos, fusionados, como agentes farmaceuticos. | |
| IL146811A0 (en) | Novel method for preparing benzoperhydroisoindole compounds | |
| IL156768A0 (en) | Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine | |
| WO2002017954A1 (fr) | Medicaments contre la maladie de parkinson | |
| MY133438A (en) | Morpholinobenzamide salts | |
| ZA200203570B (en) | beta-D-5-thioxylose derivatives, preparation method and therapeutic use. | |
| MXPA04002784A (es) | Sales farmaceuticamente aceptables de 20(s)-camptotecinas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |